
Julie Ha
Examiner (ID: 10419, Phone: (571)272-5982 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 1467 |
| Issued Applications | 922 |
| Pending Applications | 143 |
| Abandoned Applications | 441 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18293897
[patent_doc_number] => 20230103583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => METHOD OF ENHANCING AQUEOUS HUMOR OUTFLOW AND REDUCING INTRAOCULAR PRESSURE
[patent_app_type] => utility
[patent_app_number] => 17/802676
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802676 | METHOD OF ENHANCING AQUEOUS HUMOR OUTFLOW AND REDUCING INTRAOCULAR PRESSURE | Feb 25, 2021 | Abandoned |
Array
(
[id] => 18496168
[patent_doc_number] => 20230218721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => INCRETIN ANALOGUE, PREPARATION METHOD THEREFOR, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/916169
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916169 | INCRETIN ANALOGUE, PREPARATION METHOD THEREFOR, AND USE THEREOF | Feb 25, 2021 | Pending |
Array
(
[id] => 17095317
[patent_doc_number] => 20210283108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHOD FOR TREATING NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/186435
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186435
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/186435 | METHOD FOR TREATING NEURODEGENERATIVE DISEASES | Feb 25, 2021 | Abandoned |
Array
(
[id] => 18171765
[patent_doc_number] => 11571458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health
[patent_app_type] => utility
[patent_app_number] => 17/187535
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 24957
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187535
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/187535 | Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health | Feb 25, 2021 | Issued |
Array
(
[id] => 16961604
[patent_doc_number] => 20210213103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => METHODS OF TREATING DRY EYE SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/185583
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185583
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185583 | METHODS OF TREATING DRY EYE SYNDROME | Feb 24, 2021 | Abandoned |
Array
(
[id] => 18251782
[patent_doc_number] => 20230078821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => Apoaequorin and Curcumin Containing Compositions and Methods
[patent_app_type] => utility
[patent_app_number] => 17/801619
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801619
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801619 | Apoaequorin and Curcumin Containing Compositions and Methods | Feb 22, 2021 | Pending |
Array
(
[id] => 20212572
[patent_doc_number] => 12409206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Use of cyclosporine analogues for treating fibrosis
[patent_app_type] => utility
[patent_app_number] => 17/179406
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 33
[patent_no_of_words] => 19254
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179406
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179406 | Use of cyclosporine analogues for treating fibrosis | Feb 18, 2021 | Issued |
Array
(
[id] => 18252356
[patent_doc_number] => 20230079395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => OPHTHALMIC PHARMACEUTICAL COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/795836
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795836 | OPHTHALMIC PHARMACEUTICAL COMPOSITION AND USE THEREOF | Feb 11, 2021 | Pending |
Array
(
[id] => 18228966
[patent_doc_number] => 20230067960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => TRIPLE AGONIST FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR, GLUCAGON RECEPTOR, AND GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 17/788738
[patent_app_country] => US
[patent_app_date] => 2021-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788738 | TRIPLE AGONIST FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR, GLUCAGON RECEPTOR, AND GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR | Feb 6, 2021 | Pending |
Array
(
[id] => 16870072
[patent_doc_number] => 20210163539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => Wet Adhesive Peptides
[patent_app_type] => utility
[patent_app_number] => 17/163733
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17163733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/163733 | Wet adhesive peptides | Jan 31, 2021 | Issued |
Array
(
[id] => 18932341
[patent_doc_number] => 11884748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
[patent_app_type] => utility
[patent_app_number] => 17/161370
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 62127
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17161370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/161370 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Jan 27, 2021 | Issued |
Array
(
[id] => 18293989
[patent_doc_number] => 20230103675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => ALLERGEN PROTECTION FOR THE SKIN
[patent_app_type] => utility
[patent_app_number] => 17/759634
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759634
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759634 | ALLERGEN PROTECTION FOR THE SKIN | Jan 25, 2021 | Pending |
Array
(
[id] => 18299471
[patent_doc_number] => 20230109157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES AS ALLERGEN PROTECTION FOR THE SKIN
[patent_app_type] => utility
[patent_app_number] => 17/759635
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759635
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759635 | TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES AS ALLERGEN PROTECTION FOR THE SKIN | Jan 25, 2021 | Pending |
Array
(
[id] => 18227055
[patent_doc_number] => 20230066049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => PEPTIDES USEFUL IN PRESERVATION AND/OR RESTORATION OF FUNCTIONAL PANCREATIC ISLETS AND IN TREATING DIABETES
[patent_app_type] => utility
[patent_app_number] => 17/759712
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759712
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759712 | PEPTIDES USEFUL IN PRESERVATION AND/OR RESTORATION OF FUNCTIONAL PANCREATIC ISLETS AND IN TREATING DIABETES | Jan 25, 2021 | Pending |
Array
(
[id] => 18266763
[patent_doc_number] => 20230088005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => THERAPEUTIC USES OF DULAGLUTIDE
[patent_app_type] => utility
[patent_app_number] => 17/795797
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795797 | THERAPEUTIC USES OF DULAGLUTIDE | Jan 21, 2021 | Pending |
Array
(
[id] => 18529955
[patent_doc_number] => 20230235022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => NEUTROPHIL ELASTASE BINDING PEPTIDES AND COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/793545
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793545 | NEUTROPHIL ELASTASE BINDING PEPTIDES AND COMPOSITIONS THEREOF | Jan 18, 2021 | Pending |
Array
(
[id] => 18347207
[patent_doc_number] => 20230135317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => COSMETIC FORMULATION FOR TOPICAL ADMINISTRATION COMPRISING NOVEL PEPTIDES THAT IMPROVE APPEARANCE AND REGENERATION OF SKIN
[patent_app_type] => utility
[patent_app_number] => 17/793854
[patent_app_country] => US
[patent_app_date] => 2021-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793854 | COSMETIC FORMULATION FOR TOPICAL ADMINISTRATION COMPRISING NOVEL PEPTIDES THAT IMPROVE APPEARANCE AND REGENERATION OF SKIN | Jan 17, 2021 | Pending |
Array
(
[id] => 18210331
[patent_doc_number] => 20230056593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => ARGININE ASPARTATE-CONTAINING COMPOSITION FOR SUPPRESSING OLD PERSON SMELL
[patent_app_type] => utility
[patent_app_number] => 17/792844
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792844
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792844 | ARGININE ASPARTATE-CONTAINING COMPOSITION FOR SUPPRESSING OLD PERSON SMELL | Jan 12, 2021 | Pending |
Array
(
[id] => 18027800
[patent_doc_number] => 11510961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof
[patent_app_type] => utility
[patent_app_number] => 17/129837
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 3488
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129837
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/129837 | Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof | Dec 20, 2020 | Issued |
Array
(
[id] => 18412103
[patent_doc_number] => 11666630
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Polypeptides for managing viral infections
[patent_app_type] => utility
[patent_app_number] => 17/127161
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 41
[patent_no_of_words] => 23822
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127161
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127161 | Polypeptides for managing viral infections | Dec 17, 2020 | Issued |